The Europe Microsampling Devices Market was valued at $12.91 Million in 2024 and projected to reach to $19.41 Million by 2029, representing a compound annual growth rate of 8.5%. Europe's microsampling devices market is positioned for sustained growth, expanding from $12.91 million in 2024 to $19.41 million by 2029 at an 8.5% CAGR, outpacing the global growth rate of 7.6%.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Germany dominates Europe's microsampling devices market with $13.97 million in market size, driven by advanced healthcare infrastructure and strong pharmaceutical R&D capabilities across the region.
European regulatory bodies actively support minimally invasive diagnostic technologies, creating a favorable environment for microsampling device adoption and innovation across member states.
Increasing adoption of point-of-care testing solutions across European healthcare systems is accelerating microsampling device deployment in clinical laboratories and decentralized testing settings.
Europe's strong emphasis on patient-centric healthcare models is driving demand for less invasive sampling methods that improve patient comfort and compliance with diagnostic procedures.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LANCETS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 7.6% from 2024 to 2029 |
| Largest Segment | SINGLE-USE BLOOD COLLECTION DEVICES (Usability) |
| Market Size Base Year (Billions) | ~USD 0.09 (2024) |
| Revenue Forecast (Billions) | ~USD 0.14 (2029) |
| Segments Covered | Product, Sample Type, Collection Method, Device Type, Usability, Application |
6 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL TRIALS & RESEARCH | 5.18 | 5.3 | 5.45 | 5.65 | 5.91 | 6.26 | 6.7 | 7.26 | 5.9 |
| DISEASE DIAGNOSTICS | 6.87 | 7.1 | 7.38 | 7.73 | 8.16 | 8.72 | 9.42 | 10.29 | 6.9 |
| HEALTH SCREENING & PREVENTIVE HEALTH | 12.08 | 12.66 | 13.34 | 14.17 | 15.18 | 16.47 | 18.06 | 20.05 | 8.5 |
| OTHER APPLICATIONS | 1.34 | 1.36 | 1.39 | 1.44 | 1.49 | 1.57 | 1.67 | 1.8 | 5.2 |
| TOTAL | 25.47 | 26.42 | 27.55 | 28.98 | 30.75 | 33.02 | 35.85 | 39.39 | 7.4 |
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL TRIALS & RESEARCH | 0.92 | 0.95 | 1 | 1.05 | 1.11 | 1.19 | 1.29 | 1.42 | 7.4 |
| DISEASE DIAGNOSTICS | 1.1 | 1.16 | 1.23 | 1.3 | 1.4 | 1.52 | 1.67 | 1.85 | 8.6 |
| HEALTH SCREENING & PREVENTIVE HEALTH | 2.01 | 2.13 | 2.28 | 2.46 | 2.67 | 2.94 | 3.28 | 3.69 | 10.1 |
| OTHER APPLICATIONS | 0.21 | 0.21 | 0.22 | 0.23 | 0.24 | 0.26 | 0.28 | 0.31 | 6.8 |
| TOTAL | 4.24 | 4.46 | 4.72 | 5.04 | 5.43 | 5.92 | 6.52 | 7.28 | 9 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 13.97 Million |
| UK | USD 5.42 Million |
| France | USD 3.21 Million |
| Italy | USD 1.66 Million |
| Spain | USD 1.35 Million |
| Rest Of Europe | USD 3.75 Million |
Europe's microsampling devices market was valued at $12.91 million in 2024 and is expected to grow to $19.41 million by 2029.
Europe's microsampling devices market is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2029.
Europe's pharmaceutical research, clinical diagnostics, and personalized medicine sectors are primary drivers, supported by regulatory frameworks and reimbursement policies that favor minimally invasive sampling technologies.
Europe's stringent quality standards and established regulatory pathways facilitate market adoption, while reimbursement frameworks encourage healthcare providers and research institutions to integrate microsampling solutions into their operations.
In Europe, microsampling devices reduce sample volumes, improve patient compliance, minimize contamination risks, and support point-of-care testing initiatives aligned with the region's focus on personalized and efficient healthcare delivery.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the at-home blood collection devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
YourBio Health |
Sales Executive |
|
Capitainer |
Sales Executive |
Both top-down and bottom-up approaches were used to estimate and validate the at-home blood collection devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
At-home blood collection devices are tools designed to allow individuals or professionals to collect small blood samples from home care settings. These devices are easy to use and minimally invasive, making them suitable for various applications.
MarketsandMarkets offers the following customizations for this market report.
Full forecast, segment splits, and company analysis for all Microsampling Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report